The blue-chip Dow Jones Industrial Average closed at a record high on Friday as a subdued US inflation report lifted ...

ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...

Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...

New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.

This summary of current health news includes FDA approvals for new drugs by Bristol Myers and GE HealthCare, public health ...

The landmark approval of our first-in-class treatment for schizophrenia marks an important milestone for the community, where ...

The FDA has approved Cobenfy, the first new schizophrenia treatment in 30 years, offering a novel approach with fewer side ...

New schizophrenia treatment Cobenfy approved by US regulators, offering hope for millions with fewer side effects.

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...